|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7605 USD | -2.50% |
|
+1.40% | +38.27% |
| 15/05 | Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 19/04 | Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Cytomedix, Inc. announced the appointment of Andrew Cohen as Vice President of Marketing. He will have overall marketing responsibilities as the company moves forward with its commercial plan to launch AutoloGel(TM) in the wound care market. He will report to Dean Tozer, Executive Vice President and Chief Commercial Officer.
Most recently, Mr. Cohen was Vice President of Marketing at Millennium Laboratories.
| 1st Jan change | Capi. | |
|---|---|---|
| +38.27% | 33.65M | |
| +9.83% | 115B | |
| +10.80% | 105B | |
| -10.84% | 22.71B | |
| -1.69% | 21.83B | |
| -10.23% | 18.18B | |
| -41.92% | 16.52B | |
| -15.11% | 16.01B | |
| +6.62% | 14.14B | |
| +17.53% | 10.71B |
NUO THERAPEUTICS, INC. 
